Lethal Lying: A Tale of Two Saboteurs

BARDA Director Rick Bright and FDA Director Janet Woodcock

Americans dying during pandemic sabotaged from taking HCQ supplied by India

Biomedical Advanced Research and Development Authority (BARDA) Director Rick Bright ironically played one of the darkest roles in the early days of the pandemic when he undermined the Trump Administration’s plans to provide a supply of hydroxychloroquine (HCQ) from the National Stockpile to millions of outpatients around the country. On March 23, 2020, Secretary of Health and Human Services (HHS) Alex Azar instructed him to establish an Expanded Access Investigational New Drug (IND) authorization allowing access to HCQ outside the hospital setting.

President Trump’s promotion of HCQ was inspired by his communications with the late Vladmir Zelenko, MD, and the published research of French virologist/infectious disease specialist Didier Raoult, both of whom experienced active suppression. New York governor Andrew Cuomo signed an executive order limiting access to HCQ in spite of Dr. Zelenko’s remarkable record using it in combination with zinc. As a result, he developed a new protocol utilizing quercetin instead. France banned HCQ for treating COVID ignoring Dr. Raoult’s documented success.

Bright, a virologist promoting the vaccine agenda with no clinical experience treating patients, took it upon himself to block the HHS initiative any way he could. Strangely enough, he found a willing ally in the FDA’s Director of the Center for Drug Evaluation and Research Janet Woodcock, who as a rheumatologist was surely aware of the excellent safety record of HCQ in long term treatment of patients with autoimmune diseases. Despite that knowledge, she recommended instead issuing a limited Emergency Use Authorization (EUA) restricting use to inpatients only.

When HHS Assistant Secretary Brett Gigoir said “The EUA matters not … The drug is approved and therefore can be prescribed as per doctor’s orders,” Bright anonymously leaked emails to the Washington Post that “discussed the drug’s potential toxicity and demonstrated the political pressure to rush the drugs from India to American households.” He was removed from his post shortly afterwards and filed a whistleblower complaint which was settled on August 11th. He is now a Senior VP for the Rockefeller Foundation, and Woodcock became FDA Commissioner. 

Their conspiratorial actions resulted in a deadly delay in the acceptance by the medical community of the value of early treatment which persists to this day and is responsible for many thousands of preventable deaths in the United States and around the world. The details of this criminal sabotage are provided in the dramatic fashion of a detective thriller in true crime author John Leake’s The Courage to Face COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex, the book he wrote in collaboration with cardiologist Peter McCullough.

Adding insult to injury, the peer-reviewed literature on HCQ is horribly tainted by outright academic fraud requiring retraction of two widely-publicized papers touting fabricated evidence of dangerous cardiac toxicity in the most prestigious medical journals. In addition, other trials to test its efficacy were “designed to fail” performed late on inpatients rather than early on outpatients with toxic doses four times the recommended amount. Zinc, which blocks intracellular viral replication when it is pushed into the cells through the ionophore effect of HCQ, was not used.

Rounding up the usual suspects in this crime story, it comes as no surprise that Anthony Fauci would top the list as saboteur-in-chief with the sinister motive of promoting his own favorite expensive drug remdesivir as the only NIH-sanctioned treatment for hospitalized patients shortly after the FDA revoked the EUA for HCQ. In a dark plot twist, remdesivir, which had shown high kidney toxicity in Ebola trials, was documented to cause a 20-fold increase in acute renal failure in COVID patients without clinical benefit resulting in the WHO recommending against it.

Unfortunately, its use did not stop in the United States, and the hall of shame of those who push what is sarcastically called by nurses, “Run, death is near,” onto unsuspecting patients continues to expand each month. This malpractice list includes physicians treating COVID inpatients in most medical centers around the country. It is likely that few of these doctors, who are “just following orders” from colluding administrators, are aware that hospitals get major bonuses for prescribing it and Fauci’s NIAID gets a cut of the profits from the manufacturer Gilead.

Last, but not least in this police lineup of suspected HCQ assassins is internist Ashish Zha, who was Dean of Brown University School of Public Health when he wrote “The Snake-Oil Salesman of the Senate” in the NY Times. It summarized his rebuttal against the merits of early treatment in the medical testimonies by Drs. McCullough, Risch and Fareed during Senator Ron Johnson’s November 19, 2020 Committee Hearing. He admitted that like Fauci, he had never treated a single COVID patient, but he is now President Biden’s White House Coronavirus Response Coordinator.

With this sordid history of malfeasance, when will justice finally be done? There have been many hard-fought and sometimes successful court battles to obtain ivermectin for hospitalized COVID patients with fierce resistance from hospital legal teams. For those families who were unsuccessful in rescuing their loved ones the last recourse is a wrongful death lawsuit, and the first one has been filed against three California hospitals for using remdesivir as COVID-19 treatment without informed consent. Dr. McCullough refers to this death sentence as “therapeutic nihilism.”

The opposite of nihilism is the hope provided by FLCCC Alliance Brazilian endocrinologist Flavio Cadegiani in his recent peer-reviewed publication on the use of ivermectin for prophylaxis against COVID. Two doses every two weeks provided a 92% reduction in mortality which is quite an achievement compared to ineffective and toxic repeated vaccine boosters. Considering the prohibitions in the United States against early treatment since 2020 the final irony is that patients seeking ivermectin or HCQ often have to obtain it on their own from sources in India.